Document is current

Article History

Received: 1 February 2026

Accepted: 7 June 2026

First Online: 19 June 2026

Declarations

Ethics approval and consent to participate: This randomized controlled clinical trial was approved by the institutional ethics committee in Shandong Cancer Hospital and Institute (approval number: SDTHEC2024007022) and registered with the China Clinical Trial Registry (registration number: ChiCTR2400087409) before patient enrollment. Written informed consent was obtained from all participants. The principles of Declaration of Helsinki were followed for this study. This manuscript adheres to the applicable CONSORT guidelines.

Consent for publication: The publication was approval by all the authors. We confirm that all authors have read and approved the final version of the manuscript and consent to its publication. All data and materials presented in this manuscript are original, created by the authors, and do not require separate consent for publication from any third party.

Competing interests: The authors declare no competing interests.